
Soligenix Inc. (NASDAQ: SNGX) Highlights Encouraging Phase 3 Progress For Hybryte(TM) In Investment Webinar
(MENAFN- Investor Brand Network) A focus during the webinar was the investigator-initiated study currently being conducted at the University of Pennsylvania under the leadership of Dr. Ellen Kim. Interim results show that among the first eight patients who …